Breast Cancer - Inflammatory: Latest Research

This section has been reviewed and approved by the Cancer.Net Editorial Board, 04/2010

ON THIS PAGE: You will read about the scientific research being done now to learn more about this type of cancer and how to treat it. To see other pages, use the menu on the side of your screen.

Research for inflammatory breast cancer is ongoing. The following advances may still be under investigation in clinical trials and may not be approved or available at this time. Always discuss all diagnostic and treatment options with your doctor.

The latest trend in research is looking at the effectiveness of targeted therapies combined with chemotherapy. The drug bevacizumab (Avastin) used in combination with the established drugs such as doxorubicin, paclitaxel, and docetaxel, is being evaluated. Bevacizumab is a new drug that works by blocking the growth of new blood vessels that can bring nutrients to the cancer cells, called anti-angiogenesis.

Looking for More about Current Research?

If you would like additional information about the latest areas of research regarding inflammatory breast cancer, explore these related items:

The next section addresses how to cope with the symptoms of the disease or the side effects of its treatment. Use the menu on the side of your screen to select Coping with Side Effects, or you can select another section, to continue reading this guide.